237 related articles for article (PubMed ID: 27873118)
1. Current Update of a Carboxymethylcellulose-PEG Conjugate Platform for Delivery of Insoluble Cytotoxic Agents to Tumors.
Yang Y; Bteich J; Li SD
AAPS J; 2017 Mar; 19(2):386-396. PubMed ID: 27873118
[TBL] [Abstract][Full Text] [Related]
2. Targeting of metastasis-promoting tumor-associated fibroblasts and modulation of pancreatic tumor-associated stroma with a carboxymethylcellulose-docetaxel nanoparticle.
Ernsting MJ; Hoang B; Lohse I; Undzys E; Cao P; Do T; Gill B; Pintilie M; Hedley D; Li SD
J Control Release; 2015 May; 206():122-30. PubMed ID: 25804872
[TBL] [Abstract][Full Text] [Related]
3. Preclinical pharmacokinetic, biodistribution, and anti-cancer efficacy studies of a docetaxel-carboxymethylcellulose nanoparticle in mouse models.
Ernsting MJ; Tang WL; MacCallum NW; Li SD
Biomaterials; 2012 Feb; 33(5):1445-54. PubMed ID: 22079003
[TBL] [Abstract][Full Text] [Related]
4. Synthetic modification of carboxymethylcellulose and use thereof to prepare a nanoparticle forming conjugate of docetaxel for enhanced cytotoxicity against cancer cells.
Ernsting MJ; Tang WL; MacCallum N; Li SD
Bioconjug Chem; 2011 Dec; 22(12):2474-86. PubMed ID: 22014112
[TBL] [Abstract][Full Text] [Related]
5. A docetaxel-carboxymethylcellulose nanoparticle outperforms the approved taxane nanoformulation, Abraxane, in mouse tumor models with significant control of metastases.
Ernsting MJ; Murakami M; Undzys E; Aman A; Press B; Li SD
J Control Release; 2012 Sep; 162(3):575-81. PubMed ID: 22967490
[TBL] [Abstract][Full Text] [Related]
6. Docetaxel-carboxymethylcellulose nanoparticles target cells via a SPARC and albumin dependent mechanism.
Hoang B; Ernsting MJ; Roy A; Murakami M; Undzys E; Li SD
Biomaterials; 2015 Aug; 59():66-76. PubMed ID: 25956852
[TBL] [Abstract][Full Text] [Related]
7. Cabazitaxel-conjugated nanoparticles for docetaxel-resistant and bone metastatic prostate cancer.
Hoang B; Ernsting MJ; Tang WS; Bteich J; Undzys E; Kiyota T; Li SD
Cancer Lett; 2017 Dec; 410():169-179. PubMed ID: 28965854
[TBL] [Abstract][Full Text] [Related]
8. Using Flash Nanoprecipitation To Produce Highly Potent and Stable Cellax Nanoparticles from Amphiphilic Polymers Derived from Carboxymethyl Cellulose, Polyethylene Glycol, and Cabazitaxel.
Bteich J; McManus SA; Ernsting MJ; Mohammed MZ; Prud'homme RK; Sokoll KK
Mol Pharm; 2017 Nov; 14(11):3998-4007. PubMed ID: 28945432
[TBL] [Abstract][Full Text] [Related]
9. Docetaxel conjugate nanoparticles that target α-smooth muscle actin-expressing stromal cells suppress breast cancer metastasis.
Murakami M; Ernsting MJ; Undzys E; Holwell N; Foltz WD; Li SD
Cancer Res; 2013 Aug; 73(15):4862-71. PubMed ID: 23907638
[TBL] [Abstract][Full Text] [Related]
10. Tumor-targeted drug delivery using MR-contrasted docetaxel - carboxymethylcellulose nanoparticles.
Ernsting MJ; Foltz WD; Undzys E; Tagami T; Li SD
Biomaterials; 2012 May; 33(15):3931-41. PubMed ID: 22369962
[TBL] [Abstract][Full Text] [Related]
11. Docetaxel-carboxymethylcellulose nanoparticles display enhanced anti-tumor activity in murine models of castration-resistant prostate cancer.
Hoang B; Ernsting MJ; Murakami M; Undzys E; Li SD
Int J Pharm; 2014 Aug; 471(1-2):224-33. PubMed ID: 24853460
[TBL] [Abstract][Full Text] [Related]
12. Carboxymethylcellulose-based and docetaxel-loaded nanoparticles circumvent P-glycoprotein-mediated multidrug resistance.
Roy A; Murakami M; Ernsting MJ; Hoang B; Undzys E; Li SD
Mol Pharm; 2014 Aug; 11(8):2592-9. PubMed ID: 24564177
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Tumor Penetration of Podophyllotoxin-Carboxymethylcellulose Conjugates with Various Chemical Compositions in Tumor Spheroid Culture and In Vivo Solid Tumor.
Yang Y; Roy A; Zhao Y; Undzys E; Li SD
Bioconjug Chem; 2017 May; 28(5):1505-1518. PubMed ID: 28437080
[TBL] [Abstract][Full Text] [Related]
14. Selective targeting and therapy of metastatic and multidrug resistant tumors using a long circulating podophyllotoxin nanoparticle.
Roy A; Zhao Y; Yang Y; Szeitz A; Klassen T; Li SD
Biomaterials; 2017 Aug; 137():11-22. PubMed ID: 28528299
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and evaluation of a paclitaxel-binding polymeric micelle for efficient breast cancer therapy.
Xiang J; Wu B; Zhou Z; Hu S; Piao Y; Zhou Q; Wang G; Tang J; Liu X; Shen Y
Sci China Life Sci; 2018 Apr; 61(4):436-447. PubMed ID: 29572777
[TBL] [Abstract][Full Text] [Related]
16. Targeted Delivery of Cabazitaxel by Conjugation to Albumin-PEG-folate Nanoparticles Using a Cysteine-acrylate Linker and Simple Synthesis Conditions.
Khoeeniha MK; Esfandyari-Manesh M; Behrouz H; Amini M; Varnamkhasti BS; Atyabi F; Dinarvand R
Curr Drug Deliv; 2017; 14(8):1120-1129. PubMed ID: 27875950
[TBL] [Abstract][Full Text] [Related]
17. Development of docetaxel-loaded intravenous formulation, Nanoxel-PM™ using polymer-based delivery system.
Lee SW; Yun MH; Jeong SW; In CH; Kim JY; Seo MH; Pai CM; Kim SO
J Control Release; 2011 Oct; 155(2):262-71. PubMed ID: 21704664
[TBL] [Abstract][Full Text] [Related]
18. A Novel Dextran-Based Dual Drug Conjugate Targeted Tumors with High Biodistribution Ratio of Tumors to Normal Tissues.
Liu J; Zhang N; Wu J; Dong P; Lv H; Wang Q; Wang S; Yang H; Wang S; Li X; Hu J; Wang A; Li DJ; Shi Y
Int J Nanomedicine; 2022; 17():4895-4910. PubMed ID: 36262192
[TBL] [Abstract][Full Text] [Related]
19. A highly tumor-targeted nanoparticle of podophyllotoxin penetrated tumor core and regressed multidrug resistant tumors.
Roy A; Ernsting MJ; Undzys E; Li SD
Biomaterials; 2015 Jun; 52():335-46. PubMed ID: 25818440
[TBL] [Abstract][Full Text] [Related]
20. Enhanced antitumor efficacy and decreased toxicity by self-associated docetaxel in phospholipid-based micelles.
Tong SW; Xiang B; Dong DW; Qi XR
Int J Pharm; 2012 Sep; 434(1-2):413-9. PubMed ID: 22698861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
